Your browser doesn't support javascript.
loading
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage, Luís Alberto; Barreto, Guilherme Carneiro; Culler, Hebert Fabricio; Cavalcante, Jéssica Billar; de Oliveira Alves, Lucas Bassolli; Nardinelli, Luciana; Bendit, Israel; Zerbini, Maria Cláudia Nogueira; Rocha, Vanderson; Pereira, Juliana.
Afiliação
  • de Pádua Covas Lage LA; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Barreto GC; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, University of São Paulo (USP), São Paulo, SP, Brazil.
  • Culler HF; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Cavalcante JB; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • de Oliveira Alves LB; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, University of São Paulo (USP), São Paulo, SP, Brazil.
  • Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, University of São Paulo (USP), São Paulo, SP, Brazil.
  • Bendit I; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Zerbini MCN; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
  • Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, University of São Paulo (USP), São Paulo, SP, Brazil.
  • Pereira J; Department of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.
Cancer Biomark ; 35(2): 179-191, 2022.
Article em En | MEDLINE | ID: mdl-36093687
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Linfoma de Células T Periférico / Linfadenopatia Imunoblástica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Linfoma de Células T Periférico / Linfadenopatia Imunoblástica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2022 Tipo de documento: Article